Moderna testing potential monkeypox vaccines
US Centers for Disease Control and Prevention said smallpox vaccine Jynneos is being used in monkeypox cases
Moderna Inc. is testing potential vaccines against monkeypox in pre-clinical trials as the disease spreads in the United States and Europe.
MONKEYPOX VACCINE WILL BE RELEASED FROM US STOCKPILE, CDC SAYS
The World Health Organization said on Tuesday there have been 131 confirmed monkeypox cases and 106 further suspected cases since the first was reported on May 7 outside the countries where it usually spreads.
MODERNA ASKS FDA TO AUTHORIZE COVID VACCINE FOR EMERGENCY USE IN CHILDREN UNDER 6
Moderna did not immediately respond to a request for more details on the monkeypox vaccines.
Moderna logo and stock graph are seen displayed in this illustration taken, May 3, 2022. REUTERS/Dado Ruvic/Illustration ( REUTERS/Dado Ruvic/Illustration / Reuters)
The U.S. Centers for Disease Control and Prevention said the government was in the process of releasing doses of a smallpox vaccine Jynneos, made by Bavarian Nordic A/S, for use in monkeypox cases.
CLICK HERE TO READ MORE ON FOX BUSINESS